Literature DB >> 18619962

A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a.

Dominik Spensberger1, Ruud Delwel.   

Abstract

The transcription factor ecotropic viral integration site 1 (Evi1) is associated with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) in patients due to chromosomal aberration of chromosome 3. Here we show that Evi1 interacts with the histone methyltransferase SUV39H1. The interaction requires the N-terminal part of Evi1 and the H3-specific histone methyltransferase domain, SET, of SUV39H1 without Evi1 having an inhibitory effect on SUV39H1 methyltransferase activity. Presence of SUV39H1 enhances Evi1 transcriptional repression in a dose dependent manner. In addition, Evi1 also interacts with another histone methyltransferase, G9a, but not with SET9. Our data establish an epigenetic role of Evi1 in cell transformation by recruiting higher order chromatin remodeling complexes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18619962     DOI: 10.1016/j.febslet.2008.06.056

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

Review 1.  Evi-1 as a critical regulator of leukemic cells.

Authors:  Susumu Goyama; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2010-06-08       Impact factor: 2.490

Review 2.  Histone methylation in myelodysplastic syndromes.

Authors:  Yue Wei; Irene Gañán-Gómez; Sophie Salazar-Dimicoli; Sara L McCay; Guillermo Garcia-Manero
Journal:  Epigenomics       Date:  2011-04       Impact factor: 4.778

Review 3.  SET for life: biochemical activities and biological functions of SET domain-containing proteins.

Authors:  Hans-Martin Herz; Alexander Garruss; Ali Shilatifard
Journal:  Trends Biochem Sci       Date:  2013-10-20       Impact factor: 13.807

4.  Gene therapy activates EVI1, destabilizes chromosomes.

Authors:  Cynthia E Dunbar; Andre Larochelle
Journal:  Nat Med       Date:  2010-02       Impact factor: 53.440

5.  NCI first International Workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on the biological considerations of hematological relapse following allogeneic stem cell transplantation unrelated to graft-versus-tumor effects: state of the science.

Authors:  Mitchell S Cairo; Craig T Jordan; Carlo C Maley; Clifford Chao; Ari Melnick; Scott A Armstrong; Warren Shlomchik; Jeff Molldrem; Soldano Ferrone; Crystal Mackall; Laurence Zitvogel; Michael R Bishop; Sergio A Giralt; Carl H June
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-12       Impact factor: 5.742

6.  Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1.

Authors:  Sanne Lugthart; Maria E Figueroa; Eric Bindels; Lucy Skrabanek; Peter J M Valk; Yushan Li; Stefan Meyer; Claudia Erpelinck-Verschueren; John Greally; Bob Löwenberg; Ari Melnick; Ruud Delwel
Journal:  Blood       Date:  2010-09-20       Impact factor: 22.113

7.  Zinc finger transcription factor ecotropic viral integration site 1 is induced by all-trans retinoic acid (ATRA) and acts as a dual modulator of the ATRA response.

Authors:  Sonja C Bingemann; Torsten A Konrad; Rotraud Wieser
Journal:  FEBS J       Date:  2009-10-16       Impact factor: 5.542

8.  Phosphorylation of SU(VAR)3-9 by the chromosomal kinase JIL-1.

Authors:  Joern Boeke; Catherine Regnard; Weili Cai; Jørgen Johansen; Kristen M Johansen; Peter B Becker; Axel Imhof
Journal:  PLoS One       Date:  2010-04-06       Impact factor: 3.240

Review 9.  Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

Authors:  Xuejiao Tian; Saiyang Zhang; Hong-Min Liu; Yan-Bing Zhang; Christopher A Blair; Dan Mercola; Paolo Sassone-Corsi; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

10.  Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.

Authors:  Stefan Stein; Marion G Ott; Stephan Schultze-Strasser; Anna Jauch; Barbara Burwinkel; Andrea Kinner; Manfred Schmidt; Alwin Krämer; Joachim Schwäble; Hanno Glimm; Ulrike Koehl; Carolin Preiss; Claudia Ball; Hans Martin; Gudrun Göhring; Kerstin Schwarzwaelder; Wolf-Karsten Hofmann; Kadin Karakaya; Sandrine Tchatchou; Rongxi Yang; Petra Reinecke; Klaus Kühlcke; Brigitte Schlegelberger; Adrian J Thrasher; Dieter Hoelzer; Reinhard Seger; Christof von Kalle; Manuel Grez
Journal:  Nat Med       Date:  2010-01-24       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.